Inhibitory effect of matrilysin antisense oligonucleotides on human colon cancer cell invasion in vitro

✍ Scribed by Nobuyoshi Momiyama; Naohiko Koshikawa; Takashi Ishikawa; Yasushi Ichikawa; Satoshi Hasegawa; Yoji Nagashima; Masato Mitsuhashi; Kaoru Miyazaki; Hiroshi Shimada

• Publisher: John Wiley and Sons
• Year: 1998
• Tongue: English
• Weight: 160 KB
• Volume: 22
• Category: Article
• ISSN: 0899-1987
• DOI: 10.1002/(sici)1098-2744(199805)22:1<57::aid-mc7>3.0.co;2-i

✦ Synopsis

In colorectal cancer, matrilysin (matrix metalloproteinase-7) is mainly produced by the tumor cells themselves and is thought to play an important role in tumor invasion and metastasis. In the study reported here, we examined the effects of matrilysin antisense phosphorothioate oligonucleotides on both the expression of matrilysin and the invasive potential of the human colon cancer cell line CaR-1 in vitro. To select the most specific and potent oligonucleotide sequence, we performed extensive analyses of the binding specificities of all antisense candidates in the GenBank database by using a computer program we developed. As a result, a 15-mer matrilysin-specific antisense oligonucleotide that hybridizes to the coding region of matrilysin mRNA (AS-1) and a random control oligonucleotide (CL-1) were designed. Reverse transcription-polymerase chain reaction and western blot analysis demonstrated that 10 µM AS-1 suppressed matrilysin expression at both the mRNA level (92%) and protein level (64%). In vitro invasion assays demonstrated that this same concentration of AS-1 inhibited the ability of cells to invade a reconstituted basement membrane by 50% as compared with the ability of untreated cells to do so. On the other hand, CL-1, which had the same length and GC content as AS-1, did not show any inhibitory effect. These results demonstrate that the antisense oligonucleotide AS-1 inhibits matrilysin activities in a sequence-specific manner and suggest that AS-1 has the potential to be used as an anti-metastatic agent in an in vivo experimental model of colon cancer.